Menu
Fechar
hrs4r
 I want to donate
Firma
LLUÍS RAMIÓ-TORRENTÀ
Position
Cap de Grup - R4
Group leader - R4
Projectes
Publicacions

Projectes

Neurodegeneration and Neuroinflammation

Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS) - Enfermedades Inflamatorias

Codi oficial: RD21/0002/0063 - EM Start date:01/01/2022 Data fi: 31/12/2025 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ Organisme finançador: INSTITUTO DE SALUD CARLOS III
Neurodegeneration and Neuroinflammation

PROCOGBIO Predicción de la progresión del deterioro cognitivo en la esclerosis múltiple combinando biomarcadores circulantes en sangre

Codi oficial: PI23/00517 Start date:01/01/2024 Data fi: 31/12/2026 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ, ANNA QUIROGA VARELA Organisme finançador: INSTITUTO DE SALUD CARLOS III
Neurodegeneration and Neuroinflammation

Prediciendo la Progresión del Deterioro Cognitivo en la Esclerosis Múltiple a través de biomarcadores circulantes en sangre (COGNIPROG)

Codi oficial: COGNIPROG Start date:01/09/2023 Data fi: 31/12/2025 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ Organisme finançador: ASOCIACIÓN ESCLEROSIS MULTIPLE ESPAÑA (AEDEM)
Neurodegeneration and Neuroinflammation

A RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE MS-LINE! COGNITIVE REHABILITATION PROGRAM FOR PEOPLE WITH MS

Codi oficial: ECTRIMS2024: 344 Start date:23/09/2024 Data fi: 22/09/2025 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ, ÓSCAR DANIEL AYALA NARIÑO Organisme finançador: EUROPEAN COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS
Neurodegeneration and Neuroinflammation

EM-Line!Kids: rehabilitació cognitiva des de casa per a pacients en edat pediàtrica.

Codi oficial: 2024 PROD 00183 Start date:02/12/2024 Data fi: 01/06/2026 Investigador/a principal: JORDI GICH FULLÀ Organisme finançador: AGÈNCIA DE GESTIÓ UNIVERSITARIS I RECERCA
Neurodegeneration and Neuroinflammation

Red de Enfermedades Inflamatorias (REI)

Codi oficial: RD24/0007/0005 Start date:01/01/2025 Data fi: 31/12/2027 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ Organisme finançador: INSTITUTO DE SALUD CARLOS III

Publicacions

Villacieros-alvarez, J, Lunemann, JD, Sepulveda, M, Valls-Carbó, A, Dinoto, A, Fernández, V, Vilaseca, A, Castillo, M, Arrambide, G, Bollo, L, Espejo, C, Llufriu, S, Blanco, Y, Armangue, T, Bravo, GA, Quiroga-Varela, A, Torrenta, LR, Cobo-Calvo, A, Tintore, M, Mariotto, S, Montalban, X, Comabella, M

Complement Activation Profiles Predict Clinical Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2025, 12 dx.doi.org/10.1212/NXI.0000000000200340
Fumagalli, A, Castells-Nobau, A, Trivedi, D, Garre-Olmo, J, Puig, J, Ramos, R, Ramió-Torrentà, L, Pérez-Brocal, V, Moya, A, Swann, J, Martin-Garcia, E, Maldonado, R, Fernández-Real, JM, Mayneris-Perxachs, J

Archaea methanogens are associated with cognitive performance through the shaping of gut microbiota, butyrate and histidine metabolism

Gut Microbes, 2025, 17, 2455506-2455506 dx.doi.org/10.1080/19490976.2025.2455506
Genís, D, Alemany, B, Pellerin, D, Brais, B, Dicaire, MJ, Volpini, V, Campos, B, Corral, J, Gardenyes, J, de Jorge, L, San Nicolás, H, Buxó, M, Sancho, JM, Obon, M, Roig, C, Rodriguez-Revenga, L, Alvarez-Mora, MI, Danzi, MC, Houlden, H, Zuchner, S, Márquez, F, Torrenta, LRI

Late-onset vestibulocerebellar ataxia: clinical and genetic studies in a long follow-up series of 50 patients

JOURNAL OF NEUROLOGY, 2025, 272, 235-235 dx.doi.org/10.1007/s00415-025-12964-x
Oreja-Guevara, C, Meca-Lallana, JE, Gómez-Estévez, I, Ara, JR, Pérez, MAH, Gil, JG, Torres, AMA, de la Fuente, BP, Ramió-Torrentà, L, Madueño, SE, Gascón-Giménez, F, Casanova, B, Martínez-Yélamos, S, Valcárcel, MA, Ginés, MLM, Montero, YE, Real, AML, González-Quintanilla, V, de Silanes, CL, Martínez-Rodríguez, JE, Costa-Frossard, L, Redondo, MG, Fontcuberta, AL, Castellanos-Pinedo, F, Merino, JAG, Fernández, CM, Castillo-Triviño, T, Meca-Lallana, V, Martínez, JP, Rodríguez-Antigüeedad, A, González, JMP, Morales, EA, Molina, IP, Sánchez, DMS, Varo, NH, Vázquez, MA, Barrios, JMR, Río, J

Economic burden of secondary progressive multiple sclerosis: DISCOVER study

BMC HEALTH SERVICES RESEARCH, 2025, 25, 525-525 dx.doi.org/10.1186/s12913-025-12592-1
Gonzalez-Del-Rio M, Merchan-Ruiz M, Reñé-Reñé A, Bertran-Noguer C, Ramió-Torrentà L, Zabaleta-Del-Olmo E

Cognitive interviewing study to assess the content validity of a Spanish version of the Multiple Sclerosis Health Literacy Questionnaire.

Public Health, 2025, 245, 105761-105761 dx.doi.org/10.1016/j.puhe.2025.105761
Robles-Sánchez, MA, Amil-Bujan, P, Bosch-Farré, C, Coll-Martínez, C, Arévalo, MJ, Anglada-Clofent, E, Menéndez-Díaz, R, Aroca-Alsina, M, Merchan-Ruiz, M, Pérez-Hoyos, S, Arévalo-Bernabé, AG, Montalban, X, Hernando, A, Llufriú, S, Peralta-Moncusi, S, Brieva, L, Ramo-Tello, C, Carabi, M, Solà-Valls, N, Zabay, MC, Mañé-Martínez, MA, Sastre-Garriga, J, Ramió-Torrentà, L, Bertran-Noguer, C

An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study

Frontiers in Neurology, 2025, 16 dx.doi.org/10.3389/fneur.2025.1581038
Gich J, Salavedra-Pont J, Coll-Martinez C, Quintana E, Álvarez-Bravo G, Robles-Cedeño R, Buxó M, Contreras-Rodriguez O, Ramió-Torrentà L

The nature of memory impairment in multiple sclerosis: understanding different patterns over the course of the disease

Frontiers in Psychology, 2024, 14, 1269794-1269794 dx.doi.org/10.3389/fpsyg.2023.1269794
Rosell-Díaz M, Santos-González E, Motger-Albertí A, Gallardo-Nuell L, Arnoriaga-Rodríguez M, Coll-Martínez C, Ramió-Torrentà L, Garre-Olmo J, Puig J, Ramos R, Mayneris-Perxachs J, Manuel Fernández-Real J

Lower serum ferritin levels are associated with worse cognitive performance in aging

JOURNAL OF NUTRITION HEALTH & AGING, 2024, 28, 100190-100190 dx.doi.org/10.1016/j.jnha.2024.100190
Alemany-Perna, B, Tamarit, J, Cabiscol, E, Delaspre, F, Miguela, A, Huertas-Pons, JM, Quiroga-Varela, A, Ruiz, MM, Dominguez, DL, Torrenta, L, Genis, D, Ros, J

Calcitriol Treatment Is Safe and Increases Frataxin Levels in Friedreich Ataxia Patients

MOVEMENT DISORDERS, 2024, 39, 1099-1108 dx.doi.org/10.1002/mds.29808
Fernández, OF, Costa-Frossard, L, Ginés, MLM, Escribano, PM, González, JMP, Ramió-Torrentà, L, Aladro, Y, Torres, AA, Rodríguez, EA, Labiano-Fontcuberta, A, Pascual, LL, Martínez, AM, Torres, EM, Oliva-Nacarino, P

Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis

Frontiers in Neurology, 2024, 15, 1371644-1371644 dx.doi.org/10.3389/fneur.2024.1371644

Formulari de contacte

About IDIBGI!

 menu